Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.470
-0.020 (-1.34%)
At close: Sep 1, 2026, 4:00 PM EDT
1.478
+0.008 (0.57%)
After-hours: Sep 1, 2026, 7:53 PM EDT

Microbot Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-18.51-14.74-11.63-9.86-13.28-11.36
Net Income
-16.34-13.14-11.44-10.74-13.17-11.31
Earnings Per Share
-0.26-0.29-0.73-1.05-1.81-1.59
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
67.3778.595.476.398.2115.49
Total Debt
0.880.870.110.230.460.68
Net Cash (Debt)
66.4977.735.366.157.7414.81
Net Cash Growth
104.43%1350.40%-12.92%-20.52%-47.73%-37.86%
Net Cash Per Share
1.061.700.340.601.072.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.64-13.05-8.83-8.53-11.55-9.35
Capital Expenditures
-0.29-0.06-0.03-0.03-0.08-0.07
Free Cash Flow
-17.93-13.11-8.85-8.57-11.63-9.42
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.